DocketNumber： Docket Nos. 27188-91, 1987-92.
Judges： GERBER
Filed Date： 1/16/1997
Status： Non-Precedential
Modified Date： 4/17/2021
Decisions will be entered for respondent as to the deficiency and the additions to tax under sec. 6653(a), and for petitioners as to the addition to tax under sec. 6661.
MEMORANDUM FINDINGS OF FACT AND OPINION
GERBER,
In
FINDINGS OF FACT 1997 Tax Ct. Memo LEXIS 28">*30 E. Douglas (Douglas), who signed it as the preparer on April 15, 1983.
Albert J. Henry (Henry) has a bachelor of science degree in civil engineering as well as a master's degree in business administration. Between 1962 and 1968, Henry worked as a lending officer at First National City Bank (First National) in New York City. In that capacity, subject to approval, he reviewed and prepared credit lines for businesses.
After his tenure with First National, Henry worked in Los Angeles and New York City for firms that were members of the New York Stock Exchange. In that regard, Henry prepared institutional research reports on growth companies for use by entities like mutual and pension funds, as well as banks.
Institutional reports are intended to cover a particular company's products, what the projected growth rate might be, and what sort of proprietary advantages the company might have. These reports were designed to give money managers an idea of the value of a company's stock. These reports do not incorporate information on tax matters involving the particular company in question.
Richard A. Cramer (Cramer) founded IMED, a company engaged in the design, manufacture, 1997 Tax Ct. Memo LEXIS 28">*31 and sale of electronic medical instruments, primarily a device known as an "infusion pump", and related disposable devices. From 1972 through August 1982, Cramer was a shareholder, president, chairman of the board of directors, and chief executive officer of IMED. From 1972 through August 1982, Warren K. Boynton (Boynton) was vice president of IMED. Boynton was on the board from 1972 through October 1973 and from December 1974 through August 1982.
Kevin P. Monaghan (Monaghan) served as outside general counsel to IMED from its inception in 1972 until August 1982. From August 1975 through August 1982, Monaghan was assistant secretary of the board of directors of IMED (the board). Monaghan was an attorney admitted to practice in California. Cramer, Boynton, and Monaghan were close friends as well as business associates.
Dan R. Hendrickson (Hendrickson) was hired as a corporate controller of IMED on March 8, 1976, and became treasurer of IMED on February 14, 1978. Hendrickson previously had prepared Cramer's personal income tax returns for a number of years. At IMED, Hendrickson reported directly to Cramer on the financial condition of the company and the associated tax liabilities.
The 1997 Tax Ct. Memo LEXIS 28">*32 stock of IMED was neither publicly traded on an established stock market exchange nor registered with the Securities and Exchange Commission from 1978 through 1981. The directors and three or four key officers owned approximately 75 percent of the outstanding IMED stock.
On March 1, 1978, Henry joined IMED as vice president-finance and chief financial officer (CFO). Initially, Henry was expected to raise equity for IMED and to institute financial controls. Later on, Henry was in charge of determining IMED's capital needs, preparing cash-flow forecasts, and raising cash as necessary. As IMED's CFO, Henry was directly responsible to Cramer and met with him daily. At IMED, Henry was one of the IMED officers who could meet with Cramer on an unscheduled basis. Also, occasionally Cramer and Henry would go out to dinner and discuss business. Henry also saw Boynton, who was number two in IMED's hierarchy, on a daily basis since his office was nearby. However, Henry did not have frequent contact with Monaghan at IMED.
When Henry became the CFO of IMED, Hendrickson was responsible for the accounting department. As IMED's CFO, Henry was Hendrickson's direct supervisor. Hendrickson's office, however, 1997 Tax Ct. Memo LEXIS 28">*33 was located in another building at the same office compound. When Henry began work for IMED, the accounting department had approximately 10 people who reported to Hendrickson. Later, the department expanded to approximately 50 people.
In general, Henry considered Hendrickson to be competent, diligent, and responsible. Henry believed Hendrickson would apprise him of important financial matters within the ambit of the accounting department. Also, Henry socialized with Hendrickson once every couple of months, as well as having lunch with him on a regular basis. Otherwise, Henry did not regularly socialize with the other officers and directors of IMED.
IMED also maintained outside auditors, Arthur Young & Co. (Arthur Young), which performed audits of the financial statements at the end of the fiscal year. From 1974 until 1980, the principal contact at Arthur Young was Kim Rutledge (Rutledge), an accountant. Rutledge primarily had contact with Hendrickson and his predecessor at IMED.
On March 1, 1981, Henry became a member of IMED's board of directors (the board) and remained in that position until August 1982. When Henry joined the board, Cramer, Boynton, Monaghan, and two other individuals 1997 Tax Ct. Memo LEXIS 28">*34 were on it. On occasion, prior to joining the board, Henry would present financial statements for review and brief the directors on company operations.
IMED instituted a stock option plan that it granted to certain employees. The stock options granted were intended to enable employees to participate in IMED's growth and prosperity. This particular program was managed by Cramer, Monaghan, and Hendrickson.
In the process of granting stock options to its employees, IMED required the participants to file elections pursuant to section 83(b) (section 83(b) elections). 1997 Tax Ct. Memo LEXIS 28">*35 Generally, IMED did not issue Forms W-2 or 1099 to any option grantee for the year in which the option was issued. Subsequent to the section 83(b) election, IMED did not deduct the costs of the stock options it granted to its employees because that might result in the realization of ordinary income by the recipients.
On August 17, 1979, Henry received his first stock options (1979 options). The 1979 options granted Henry the right to purchase 29,250 shares of IMED's common stock. The par value of the common stock was 15 cents per share. Henry could exercise his options to purchase stock at $ 13 per share.
On September 14, 1979, Hendrickson presented Henry with a section 83(b) form to sign. Hendrickson further informed him that this document was required to be signed in order to obtain long-term capital gains on the 1979 stock options. The document contains the note that, as a condition of exercising these particular stock options, continued employment with IMED was a requirement. The document also includes the provision that the fair market value was "none" and there were no amounts currently paid in.
The 1979 options provided that the optionee could exercise the options "in 20% increments through the fifth-year end anniversary hereof, so long as he is, at such anniversary date, still an employee or consultant to IMED". The 1997 Tax Ct. Memo LEXIS 28">*36 1979 options also contained the following vesting schedule:
| Percentage of | ||
| Shares Underlying | Earliest Date Upon | Last Date Upon |
| the Options That | Which Optionee May | Which Optionee |
| May Be Exercised | Exercise | May Exercise |
| 20 | Dec. 31, 1979 | June 30, 1984 |
| 40 | Dec. 31, 1980 | June 30, 1984 |
| 60 | Dec. 31, 1981 | June 30, 1984 |
| 80 | Dec. 31, 1982 | June 30, 1984 |
| 100 | Dec. 31, 1983 | June 30, 1984 |
The 1979 options were transferable, subject to the vesting provisions, only to persons approved by the board as "qualified offerees". The approval of the board was stated to be contingent on the receipt of a favorable opinion of counsel and could be refused if the transfer would require registration under section 5 of the Securities Act of 1933, ch. 38, 48 Stat. 74, 77, as amended,
Simultaneously with his signing of the section 83(b) election for the 1979 options, Henry was provided with a copy of a letter from IMED. Dear Option Holder: Congratulations on your recent stock option. The enclosed election, which is necessary to provide for capital gain treatment upon ultimate stock sale by you, should be signed by you (and your spouse where applicable) and returned to Dan R. Hendrickson, at IMED before September 30, 1997 Tax Ct. Memo LEXIS 28">*37 1979. The original will be filed with the Internal Revenue Service and a copy retained in the files of IMED. The second copy enclosed is for your records. You have no income to report at this time, as the election is protective only. Very truly yours, [signed] Dan R. Hendrickson Treasurer
Sometime in March 1980, Henry exercised a portion of the 1979 options to the extent that he acquired 4,000 shares of IMED common stock at $ 13 per share. The 1979 options still conferred on Henry the right to purchase the remaining 25,250 shares. On October 16, 1980, Henry sold the 4,000 shares of IMED common stock for $ 190,000.
In December 1980, John Stine (Stine) replaced Rutledge as the Arthur Young tax principal performing corporate tax work for IMED. Stine's main contact at IMED was Hendrickson. Stine also talked with Monaghan on occasion. As tax principal for Arthur Young, Stine did not consult with Henry on tax matters.
On May 29, 1981, IMED andIMED International Corp. (International), a Cayman Islands, British West Indies, corporation, formed a trust with a Swiss corporation as trustee. 1997 Tax Ct. Memo LEXIS 28">*38 individuals designated as the "Beneficiaries". The 1981 options were allocated as follows: Number of Paired Shares Exercise Price Cramer 50,000 $ 100 100,000 200 Boynton 50,000 100 Henry 50,000 100 Monaghan 25,000 100
The trust agreement was signed by Cramer, as chairman of both IMED and International. Subsequently, Henry was informed by Cramer that he would receive additional stock options. Henry did not sign or receive certificates or documents with respect to the 1981 options.
On May 27, 1981, Monaghan wrote to Hendrickson, noting that stock options in IMED had been granted to certain employees, and requesting that the aforementioned individuals sign section 83(b) elections and file them by June 17, 1981.
On October 28, 1981, Stine, of Arthur Young, sent both Monaghan and Hendrickson a letter which stated: IMED currently 1997 Tax Ct. Memo LEXIS 28">*39 takes the position that its stock options are governed by Section 83 and therefore the present tax treatment is * * * no income to the employee on grant or exercise and no compensation deduction to IMED. However, Regulation 1.83-7 states that an option must have a "readily ascertainable fair market value" before Section 83 will apply. Since the definition of "readily ascertainable fair market value" is virtually impossible to meet, IMED's present position is subject to challenge. * * *
On November 12, 1981, Monaghan informed Hendrickson that certain IMED employees had obtained options on IMED stock, but that the options "should not be delivered to the holders until their Section 83 elections have been prepared and are ready to file."
In an undated form letter from Robert Reiss, president of IMED, employees participating in the stock option plan were informed that the section 83(b) elections were "necessary to provide for capital gain treatment upon ultimate stock sale by you". This document further states that the recipient has "no income to report at this time, as the [section 83(b)] election is protective only."
In early 1982, Cramer, along with the majority of IMED's 1997 Tax Ct. Memo LEXIS 28">*40 stockholders, met with investment bankers to proceed with the sale of IMED. Henry was always present with Cramer when prospective purchasers came to perform due diligence investigations with respect to IMED.
On May 6, 1982, the management of Warner-Lambert Corp. (Warner-Lambert) approached the officers and directors of IMED to propose a transaction whereby Warner-Lambert would acquire all the outstanding stock of IMED and its subsidiaries. Initially, Warner-Lambert offered $ 480 million, subject to a due diligence investigation.
As part of the negotiations, Cramer, Monaghan, Boynton, and Henry, as IMED's executive officers, went to Warner-Lambert's corporate offices in New Jersey. As IMED's CFO, Henry was required to supply financial analyses, as well as discuss the projected market and product forecasts. At some point during the sale negotiations, Henry told Cramer that he thought that the stock options should be long-term capital gains.
In the IMED sale negotiations, the executives from both companies recognized that there would be a problem with IMED's employee stock options. Warner-Lambert realized that if the options were not exercised, then IMED would not have $ 30 million to 1997 Tax Ct. Memo LEXIS 28">*41 $ 40 million in its treasury at the time of sale. Consequently, in New Jersey, Cramer met with Ward Hagen, the chief executive officer of Warner-Lambert. When the meeting ended, Cramer told Monaghan, Boynton, and Henry that the option holders would obtain long-term capital gain treatment and instructed Monaghan to structure the transaction to achieve such long-term capital gain. Warner-Lambert was persuaded to purchase the employee stock options and to forgo a deduction in its 1982 Federal income tax return for the cost of purchasing the options. However, Warner-Lambert reduced the offer for IMED from $ 480 million to $ 465 million.
During the final negotiations, the officers and directors of IMED met with the law firm Skadden, Arps, Slate, Meagher & Flom (Skadden, Arps), which represented Warner-Lambert in New York City. After a meeting with the attorneys from Skadden, Arps in Manhattan, Monaghan informed Henry that he had structured the options as long-term capital gain. Subsequently, Monaghan told Boynton, in response to Boynton's question, that the option proceeds would be treated as long-term capital gain.
On July 8, 1982, the Swiss trust that held the 1981 options was dissolved. 1997 Tax Ct. Memo LEXIS 28">*42 The assets of the trust, the 1981 options, reverted to IMED. In August 1982, Warner-Lambert purchased all of the outstanding stock of IMED for approximately $ 163 per paired share of stock in IMED and International. Warner-Lambert paid a total of $ 465 million for all of the outstanding stock plus the extant stock options belonging to employees of IMED.
Warner-Lambert, through IMED, issued Henry a 1982 Form W-2 that was filed as part of petitioners' 1982 Federal income tax return declaring $ 92,874.60 as income. Neither Warner-Lambert nor IMED provided Henry with another Form W-2 or 1099 or other form or statement that declared his stock option proceeds as income.
Douglas, a certified public accountant, prepared petitioners' 1982 Federal income tax return. He was licensed in California and, since 1977, a partner in the firm of Jassoy, Graff & Douglas. Henry was introduced to Douglas by Hendrickson, who informed him that Douglas was an "excellent, very careful accountant". Between 1968 and 1974, Douglas worked in the tax department of Price Waterhouse. While at Price Waterhouse, Douglas was an instructor in its national tax course. Between 1974 and 1977, Douglas practiced 1997 Tax Ct. Memo LEXIS 28">*43 with George Peterson & Co.
As petitioners' accountant, Douglas prepared their 1977 through 1982 joint Federal income tax returns. Petitioners' 1978, 1979, and 1980 returns were audited by respondent. Douglas represented petitioners in these audits, which resulted in minor adjustments to petitioners' returns. Generally, Henry was satisfied with the manner in which Douglas handled the audits.
Henry informed Douglas that IMED had been sold, and that it was Henry's understanding that Monaghan, as IMED's counsel, had structured the stock options as long-term capital gain. Henry also advised Douglas that if there were any questions regarding the handling of the options to contact Monaghan or Hendrickson.
Douglas agreed with his partner, Robert W. Jassoy Jr., that the option proceeds should be classified as long-term capital gain on the income tax returns he prepared for petitioners. In reaching this decision, Douglas considered as a factor that there were no Forms W-2 or 1099, nor any other form, issued by either Warner-Lambert or IMED, declaring the option proceeds as income. Also, based on an earlier discussion with Hendrickson regarding IMED's stock option plan, Douglas surmised that 1997 Tax Ct. Memo LEXIS 28">*44 Arthur Young approved the tax treatment of the stock option proceeds based on the legislative history of section 83. In addition, Douglas believed that the attorneys representing Warner-Lambert and IMED had structured the transaction to accomplish long-term capital gain for the option holders. Finally, in reaching his decision, Douglas relied on the fact that Hendrickson had informed him about the section 83(b) elections. Douglas concluded that the elections put respondent on notice regarding the stock options. However, Douglas knew that there was a distinct possibility that respondent might challenge the classification of Henry's stock option proceeds as long-term capital gain.
Douglas prepared petitioners' 1982 joint Federal income tax return. Henry provided Douglas with the Form W-2 that he obtained, through IMED, from Warner-Lambert. Douglas, however, did not review the option documents or the option plan.
Petitioners' 1982 Federal income tax return reported income from wages of $ 92,875 and capital gain of $ 3,462,345. On the Schedule D included with their 1982 Federal income tax return, petitioners reported a short-term loss of $ 3,796 and long-term capital gains of $ 8,636,553, 1997 Tax Ct. Memo LEXIS 28">*45 the net of which resulted in the $ 3,462,345 after considering the deduction for capital gains. Next to both entries was the following reference: "SEE ATTACHED COMPUTER D".
On Schedule D, a schedule petitioners included with their 1982 Federal income tax return, they listed their capital gains. Petitioners reported:
| Productive | Date | Date | Gross Sale | Cost or | Assets | Acquired | Sold | Price | Other Basis | (Loss) |
| 10,000 shares | 1980 | 1982 | $ 1,638,100 | -0- | $ 1,638,100 | |||||
| IMED Corp. | ||||||||||
| 25,250 options | 1978 | 8/19/82 | 3,807,953 | -0- | 3,807,953 | |||||
| IMED Corp. | ||||||||||
| 50,000 options | 1981 | 8/19/82 | 3,190,500 | -0- | 3,190,500 | |||||
| IMED Corp. |
Petitioners reported a total of $ 8,636,553 as long-term capital gain in the "FEDERAL TOTALS" column. On the second page of the Schedule D, petitioners reported a net gain of $ 8,655,862.
Hendrickson had overall corporate tax responsibility within IMED. Hendrickson apprised Henry concerning matters related to petitioners' personal taxes but believed that was not specifically part of his duties at IMED. Hendrickson stated that it became apparent, sometime in 1977 or 1978, that with respect to the stock options, unless something 1997 Tax Ct. Memo LEXIS 28">*46 was changed, long-term capital gain was not a possibility. Hendrickson also believed that it would be difficult to overturn the particular regulation in question. Hendrickson warned some of the option holders that capital gain was not guaranteed. At the time of IMED's sale in 1982, Hendrickson knew that the stock option proceeds were not entitled to long-term capital gain treatment.
Monaghan was aware of "ongoing discussions" regarding the proper tax treatment of the stock options throughout the corporate life of IMED. Monaghan believed that members of the board would have been aware of these discussions, as well as Rutledge at Arthur Young. Monaghan discussed the stock options with Henry.
Monaghan believed that upon analyzing the tax provisions related to stock options, a section 83(b) election would ensure that the proceeds would be treated as long-term capital gain. However, Monaghan understood that there were some risks associated with the section 83(b) election for the stock optionees.
Boynton believed that there had been no discussions among the officers and directors of IMED who were negotiating the sale of the company to Warner-Lambert regarding the taxation of the employee 1997 Tax Ct. Memo LEXIS 28">*47 stock options. However, Boynton was aware of discussions of how Warner-Lambert would acquire the outstanding employee stock options. Boynton discussed the tax treatment of the proceeds of the IMED options only with Monaghan. Boynton was otherwise unaware of the possibility that respondent might challenge the long-term capital gain treatment of his stock option proceeds and considered it Hendrickson's responsibility to handle tax matters as well as the stock option plan.
As the chief executive officer of IMED and majority stockholder, Cramer considered Henry to be an important individual in the company. However, Cramer considered Henry to be "the one outsider" in IMED. The 1981 options granted to Henry were for services rendered, although Cramer noted that Henry had not yet accomplished anything of substance at the time of the grant.
OPINION
Petitioners concede that they are liable for the underlying income tax deficiency but contend that they are not liable for the additions to tax. In that regard, petitioners bear the burden of proof with respect to the additions to tax. Rule 142(a);
Respondent argues that petitioners were negligent 1997 Tax Ct. Memo LEXIS 28">*48 inasmuch as they knew that: (1) When granted, the options did not have readily ascertainable fair market values; (2) the options did not have fair market values of zero at the time they filed their section 83(b) elections; and (3) at the time the 1982 Federal income tax returns were filed, their positions were subject to challenge. Petitioners, on the other hand, contend that they did not misrepresent the sale of the options, relied on professional advisers, and acted in good faith in reporting the sales of the options. The success of petitioners' contentions is dependent in part on their claim that they were unaware of the concerns of other top echelon officers of IMED, even though Henry was a director and part of that group.
For 1982, section 6653(a) (1) provides for an addition to tax equal to 5 percent of the underpayment in tax if any part of the underpayment is due to negligence or intentional disregard of rules and regulations. Section 6653(a) (2) provides for an addition to tax equal to 50 percent of the interest payable under section 6601 on that portion of the underpayment in tax attributable to such negligence or intentional disregard.
Negligence is defined as the failure 1997 Tax Ct. Memo LEXIS 28">*49 to exercise the due care that a reasonable and ordinarily prudent person would employ under the circumstances.
A taxpayer may avoid liability for the additions to tax under section 6653(a) (1) and (2) by relying on competent professional advice if it was reasonable to rely on such advice.
There were three taxpayers before this Court in
Here, petitioners argue that they were in a different position from the
Under the circumstances here, petitioners' reliance was not reasonable. We agree with respondent that petitioners were negligent in reporting the proceeds from the sale of the options as long-term capital gain on their 1982 return. Their claims of good faith are not supported by the record.
Petitioners contend that Douglas alone made the 1997 Tax Ct. Memo LEXIS 28">*52 decision to classify the option proceeds as long-term capital gain. Petitioners further contend that they had no reason to question Douglas' classification of the option proceeds as long-term capital gain. Petitioners explain that when Douglas was hired as their accountant, Henry was informed that Douglas had an impressive professional background. In addition, petitioners were pleased with Douglas' representation in several audits of prior years. Accordingly, petitioners argue that, at the time Douglas started work on petitioners' joint 1982 Federal income tax return, they had every reason to rely on his professional acumen.
Respondent points out, however, that Henry was a sophisticated businessman who functioned in a highly competitive environment and should not be allowed to claim reliance on his adviser if he failed to provide the adviser with correct and complete information. See
Douglas stated that he alone determined that the stock option proceeds were long-term capital gain in petitioners' joint 1982 Federal income 1997 Tax Ct. Memo LEXIS 28">*53 tax return. In his testimony, Douglas discussed various factors that he incorporated in his ultimate conclusion that the stock option proceeds were capital gain. Douglas, however, was not sufficiently informed to reach that conclusion. He knew that there was a chance that respondent would challenge the tax treatment. Henry told Douglas to ask for more information from either Monaghan or Hendrickson with respect to the stock option plan. However, Henry specifically informed Douglas that long-term capital gain treatment for the stock option proceeds was warranted.
Douglas admitted that petitioners did not provide him with certain relevant information such as copies of the 1979 or the 1981 IMED options. Petitioners did not provide an explanation as to why these particular documents were not produced to their accountant. In other words, petitioners failed to provide their accountant with sufficient information to render a fully informed opinion concerning the relevant facts and law. See
Henry contends that he reasonably believed that the stock option proceeds were long-term capital gain, for the following reasons: (1) Because of IMED's section 83(b) program; (2) the fair market value of the stock options was entered as zero in the election that Henry signed; (3) IMED provided Henry with a letter that stated that the election "is necessary to provide for capital gain treatment upon ultimate stock sale"; (4) Hendrickson informed Henry that the election was necessary to obtain long-term capital gain treatment; (5) Henry was informed that the option proceeds were long-term capital gain by both Cramer and Monaghan; (6) subsequent to IMED's sale, Henry did not possess Forms W-2 or 1099 that reflected the stock option proceeds as income.
Although there were many self-serving assertions that capital gains were the proper treatment, the record supports our finding that petitioners were aware that the stock option proceeds were not properly characterized as long-term capital gain. In particular, in March 1980, 1997 Tax Ct. Memo LEXIS 28">*55 Henry exercised the right to acquire 4,000 shares of IMED common stock for $ 13 per share. Later, Henry sold these shares of stock on October 16, 1980, for $ 190,000. Thus, petitioners sold the shares for $ 47.50 per share, some $ 34.50 more than the option price. Moreover, Henry's education and work experience enabled him to value stock and growth projections for companies. Consequently, Henry knew or should have known that the section 83(b) election, which he signed in September of 1979, was invalid insofar as it stated that the fair market value of the 1979 options was zero.
Also, petitioners cannot rely on Hendrickson's statements made concerning the election nor the IMED form letter obtained on September 14, 1979, to negate additions to tax for negligence attributable to their 1982 return. In general, petitioners had an obligation to independently verify their own proper income tax liability. In other words, petitioners failed to ask pertinent questions or even make a cursory investigation beyond the information provided to them concerning the IMED stock options. See
Henry argues that he was not part of the core group that controlled IMED and that he would not be privy to the "ongoing" discussions with Cramer, Monaghan, and Boynton regarding the stock options. Respondent, however, points to the fact that Hendrickson was responsible to Henry in the organizational scheme within IMED. In other words, Hendrickson's responsibility as the head of IMED's accounting department included conveying his interpretations of the Internal Revenue Code to Henry.
Hendrickson's responsibilities in the corporation included informally advising Henry with respect to his own taxes. Henry and Hendrickson socialized once every couple of months, as well as having lunch with each other on a regular basis. In connection with the sale negotiations with Warner-Lambert, Henry was required to supply financial analyses, as well as discuss the projected market and product forecasts. Although Henry's responsibilities 1997 Tax Ct. Memo LEXIS 28">*57 did not specifically encompass taxation issues, the tax treatment of the stock options was a critical consideration. In particular, we note that a major item that was negotiated involved Warner-Lambert's forgoing a deduction on its 1982 Federal income tax return for the payment of the option purchase proceeds. That issue was important enough for Cramer to meet with the head of Warner-Lambert. Also, Henry admitted, during the sale negotiations, he expressed his belief to Cramer that the stock option proceeds should be long-term capital gain. At the very least, Henry was aware that Warner-Lambert chose to coordinate with IMED on the issue of the proper taxation of the outstanding stock options.
Hendrickson introduced Douglas to Henry and gave Douglas an excellent recommendation. Douglas had been in contact with Hendrickson regarding the IMED stock option plan when it was set up, and he gave Douglas the impression that Arthur Young had approved of the tax treatment of IMED's stock option plan. Hendrickson addressed important tax matters with Henry and also likely apprised him of the issue of the proper characterization of the stock option proceeds.
It should also be noted that in 1981 1997 Tax Ct. Memo LEXIS 28">*58 Hendrickson was placed on notice by the Stine letter that because "the definition of 'readily ascertainable fair market value' is virtually impossible to meet, IMED's present position [that section 83 governed IMED's stock options] is subject to challenge." The top executives and officers of IMED believed that the proper treatment of the stock option proceeds was as long-term capital gain. Yet the record does not reflect that their belief was based on thorough research or analysis. Nor did they consult their tax professionals concerning the section 83 option issue. In this setting, the Stine letter is the only in-depth inquiry concerning the proper taxation of the income from the option proceeds. It appears improbable that the significance of the Stine letter would escape Henry and Hendrickson, especially because it contained an opinion contrary to their hoped-for capital gains reporting of the IMED stock options.
Finally, Cramer and Monaghan informed Henry at the IMED sale negotiations in New Jersey that the stock option proceeds would be structured as capital gain. In general, tax reduction is an acceptable goal as long as the reduction involves transactions with substance and is 1997 Tax Ct. Memo LEXIS 28">*59 by legal means.
There were numerous opportunities for petitioners to learn of the questionable status of the capital gain tax treatment of the stock options. Hendrickson warned at least some of the IMED stock optionees at the time they signed their section 83(b) elections that the IMED options program was contrary to the regulations promulgated by respondent. Monaghan knew there was a possibility that the Commissioner would challenge IMED's treatment of the stock option proceeds, and he initiated "ongoing" discussions among the officers and directors of IMED concerning this particular issue. Also, Cramer advised the other three IMED negotiators (which included Henry), subsequent to a meeting with the chief executive officer of Warner-Lambert, that the option proceeds would be deemed long-term capital gain. This rebuts petitioners' contention that the options were not considered in the sale negotiations with Warner-Lambert. Additionally, Henry did not provide any other reasonable explanation as to why Warner-Lambert decreased the final purchase price 1997 Tax Ct. Memo LEXIS 28">*60 paid for IMED from $ 480 million to $ 465 million. In these circumstances, Henry's plea of ignorance does not ring true. Henry's involvement at the top level of IMED and in the Warner-Lambert negotiations undermines his plea of ignorance, and we so find. Cf.
In
Although Cramer referred to Henry as "the one outsider" on IMED's board, he met with 1997 Tax Ct. Memo LEXIS 28">*61 Henry on a daily basis and occasionally went out to dinner with him. Also, Henry was involved in the negotiations regarding the sale of IMED to Warner-Lambert and was one of the four IMED executives who were delegated to pursue the sale negotiations with Warner-Lambert. Henry and the other top level IMED officers possessed significant amounts of the 1981 options. The potential value and possible tax treatment of the options to the IMED officers was certain to be a prominent topic of conversation. We find it difficult to believe that IMED's chief financial officer would not be privy to this and/or be oblivious to the concerns of the other officers, who, along with Henry, ran IMED. Henry may have entered the top echelon of IMED after Cramer and his nucleus of associates, but he was not an "outsider" regarding IMED's daily business operations.
Respondent's determination that petitioners were negligent is sustained. Petitioners' claims of good faith are undermined by the totality of the circumstances. Based on the testimony from Hendrickson, Monaghan, and Douglas, the record demonstrates that Henry was aware of the risks involved in reporting all of the proceeds from the sale of the 1979 1997 Tax Ct. Memo LEXIS 28">*62 and 1981 stock options as long-term capital gain. Moreover, Henry did not provide Douglas with all the information Henry knew about the 1979 or 1981 options. For example, if Douglas had been made aware of the fact that the value of the 1979 options was not zero, that would likely have had a profound effect on the accountant's evaluation of the proper tax treatment of the option proceeds. Finally, the fact that Henry referred Douglas to either Hendrickson or Monaghan if there were any questions regarding IMED's stock option program does not obviate Henry's responsibility to ensure that the 1982 return was accurately filed. See
Next, petitioners contend that respondent erred in determining additions to tax for substantial understatements under section 6661. Section 6661(a) imposes an addition to tax when there is a "substantial understatement of income tax for any taxable year". As applicable here, the addition to tax 1997 Tax Ct. Memo LEXIS 28">*63 under section 6661(a) is equal to 25 percent of the underpayment attributable to the substantial understatement.
Section 6661(b)(2)(A) defines "understatement" as the excess of the amount of tax required to be shown on the return over the amount of tax actually reported on the return. This understatement will be "substantial" if the amount of such understatement exceeds the greater of 10 percent of the amount of tax required to be shown on the return for the taxable year, or $ 5,000. Sec. 6661(b)(1)(A).
The section 6661 addition to tax is not applicable, however, if there was substantial authority for the position taken on the taxpayer's return, or adequate disclosure in the return of the relevant facts affecting the treatment of the item. Sec. 6661(b)(2)(B)(i) and (ii).
Petitioners have not contended that there was substantial authority for their reporting position. Petitioners contend that the tax treatment of the proceeds of the sale of IMED's stock options was adequately disclosed in their return as filed. Respondent 1997 Tax Ct. Memo LEXIS 28">*64 disputes that petitioners adequately disclosed the item in question.
In
Petitioners' expert witness, John J. Monaco (Monaco), was previously Assistant Commissioner (Examination) for respondent, where he was an employee for 33 years. Monaco opined that the zero basis reported on the return would be adequate disclosure of the relevant facts. Monaco concluded that such disclosure was sufficient to apprise respondent of the facts and the nature of the potential controversy concerning the tax treatment of the item. Monaco decided that the zero basis "would be a clear indication that the options had been awarded 1997 Tax Ct. Memo LEXIS 28">*65 to the employee as compensatory stock options and that no value had been reflected in * * * [Henry's] income either at the time the options were received or at any other time prior to the sale of such option." Monaco stated that there was no other likely explanation for a zero basis. Monaco opined that the zero basis reported on petitioners' 1982 return was sufficient to apprise respondent of the tax treatment of the item in question. Based on his experience, Monaco believed that a return with a reported zero basis for employee stock options and claimed capital gain treatment would be selected for examination.
In the present cases, petitioners' 1982 return identified the property in question and clearly distinguished between stocks and options. 1997 Tax Ct. Memo LEXIS 28">*66 gain.
We hold that petitioners adequately disclosed the information and are not liable for the addition to tax under section 6661. Interest
Petitioners argue that we should abate interest on the income tax deficiency pursuant to section 6404(e) because of respondent's delay in issuing the notice of deficiency. Specifically, petitioners assert that respondent was dilatory in issuing the notice of deficiency, thus increasing the interest payable.
The United States Tax Court is a court of limited jurisdiction. See sec. 7442;
To reflect the foregoing,
1. All section references are to the Internal Revenue Code in effect for the year at issue, and all Rule references are to the Tax Court Rules of Practice and Procedure, unless otherwise indicated.↩
2. The parties' stipulation of facts and exhibits are incorporated by this reference.↩
3. Sec. 83(a) provides generally that if property is transferred to an individual as compensation for services, recognition of income will be deferred if the property is not transferable or is subject to a substantial risk of forfeiture.
Sec. 83(b) provides, in relevant part, that the employee may elect within 30 days of receipt to include the value of the property for the year he receives it, despite the fact that such property is nontransferable and forfeitable.
4. On October 3, 1980, the outstanding shares of IMED and International were "paired" so that the stock of neither company could be issued or sold without the simultaneous issuance or sale of an equal number of shares of the other company.↩
1. There are two other beneficiaries who were members of IMED's board, but they are not part of these cases, and hence, need not be identified.↩
1. This column reflects gains reported under the category of "More than 1, 5 years or less".↩
5. It should be noted that in
6. Accordingly, we do not reach petitioners' argument with respect to sec. 6661(c).↩
Neely v. Commissioner ( 1985 )
LaVerne v. Commissioner ( 1990 )
Frank Lyon Co. v. United States ( 1978 )
Freytag v. Commissioner ( 1991 )
Pallottini v. Commissioner ( 1988 )
Cramer v. Commissioner ( 1993 )
United States v. Boyle ( 1985 )
United States v. Charles Demore Jewell ( 1976 )
thomas-l-freytag-and-sharon-n-freytag-v-commissioner-of-internal ( 1990 )
Richard A. Cramer Alice D. Cramer Warren K. Boynton Susi M. ... ( 1995 )
Leo Goldman and Pauline Goldman v. Commissioner of Internal ... ( 1994 )
Commissioner v. McCoy ( 1987 )
508 Clinton St. Corp. v. Commissioner ( 1987 )
George v. Zmuda and Walburga Zmuda v. Commissioner of ... ( 1984 )